Gars1-flox 基因敲除小鼠

1. Markovitz, Rebecca, Ghosh, Rajarshi, Kuo, Molly E, Xiao, Rui, Potocki, Lorraine. 2020. GARS-related disease in infantile spinal muscular atrophy: Implications for diagnosis and treatment. In American journal of medical genetics. Part A, 182, 1167-1176. doi:10.1002/ajmg.a.61544. https://pubmed.ncbi.nlm.nih.gov/32181591/

2. Nie, Jianqiang, Liu, Taobin, Mao, Taotao, Liu, Xiaoqiang, Fu, Bin. 2023. Transcriptome sequencing and single-cell sequencing analysis identify GARS1 as a potential prognostic and immunotherapeutic biomarker for multiple cancers, including bladder cancer. In Frontiers in immunology, 14, 1169588. doi:10.3389/fimmu.2023.1169588. https://pubmed.ncbi.nlm.nih.gov/37404826/

3. Huang, Yufeng, Bi, Bo, Zhao, Peiwei, Liu, Jie, He, Xuelian. 2021. Infantile-onset CMT2D/dSMA-V in a Chinese family with parental germline mosaicism for a novel mutation in the GARS1 gene. In Molecular genetics & genomic medicine, 10, e1846. doi:10.1002/mgg3.1846. https://pubmed.ncbi.nlm.nih.gov/34898052/

4. Jiménez-Jiménez, Jesús, Navarrete, Irene, Azorín, Inmaculada, Sevilla, Teresa, Sivera, Rafael. 2024. Insights into phenotypic variability caused by GARS1 pathogenic variants. In European journal of neurology, 31, e16416. doi:10.1111/ene.16416. https://pubmed.ncbi.nlm.nih.gov/39051710/

5. Liu, Weihui, Wei, Chengcheng, He, Qingliu, Guo, Yihong, Xue, Xueyi. 2024. Multiple omics integrative analysis identifies GARS1 as a novel prognostic and immunological biomarker: from pan-cancer to bladder cancer. In Scientific reports, 14, 19025. doi:10.1038/s41598-024-70041-1. https://pubmed.ncbi.nlm.nih.gov/39152248/